April 07, 2019 | News
FabRx directors, Sarah Trenfield and Alvaro Goyanes, have provided their expert opinion on 3D printing in a recent article published by ‘Innovations in Pharmaceutical Technology’. The article provides an overview of the benefits of 3D printing in healthcare, the challenges to integration and a forward-looking approach to how best this technology could be integrated in the future.
You can access the article here for free to find out more. This article is taken from Innovations in Pharmaceutical Technology April 2019, pages 12-14. © Samedan Ltd.
Copyright © 2018 FabRx Ltd